1 domain / 2 areas / 1 specialization
The Conscious Fund
Data updated
The Conscious Fund is a venture capital adviser and fund focused on early-stage psychedelic medicine and adjacent therapeutic innovation. Its public materials describe the firm as backing pioneers of psychedelic medicine, state of mind, and advanced therapeutics, and an SEC Form ADV identifies its legal entity as TCF Management LLC.
The firm’s relevance in the psychedelic ecosystem comes from its explicit specialization in psychedelic medicine and its role as an early-stage investor in the sector. Public materials also indicate a global investment lens, with the firm describing itself as investing in global early-stage ventures in psychedelic medicine.
Investor Context
Venture CapitalInvestment Context
This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.
Public Portfolio Examples
- Mindleap HealthSeed - $11.5M - Feb 1, 2022
The Conscious Fund positions itself as a specialist investor in psychedelic medicine, with a public emphasis on pre-seed and seed opportunities and a broader interest in state-of-mind and advanced therapeutics. Its materials and filings suggest a U.S.-based operating presence while its investment thesis is global, making it a niche capital provider for founders building in psychedelic therapy, drug development, and related care infrastructure.
Investor Type
Venture Capital Fund
Geographic Scope
Global
Psychedelic Focus
Explicit Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Recorded Investments
Mindleap Health
Feb 1, 2022
Seed - $11.5M
Publicly listed as part of a seed round syndicate in psychedelic/mental health technology.
The Conscious Fund Portfolio Investments, The Conscious Fund Funds, The Conscious Fund ExitsQuick Facts
- Founded
- 2018
- HQ
- Lewes, Delaware, United States
- Website
- Visit